Drugs that contain Benzoyl Peroxide
1. List of Epsolay drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9868103 | GALDERMA LABS LP | Metal oxide coating of water insoluble ingredients |
Aug, 2028
(5 years from now) | |
| US9687465 | GALDERMA LABS LP | Compositions for the treatment of rosacea |
Nov, 2032
(9 years from now) | |
| US10945987 | GALDERMA LABS LP | Method for providing early onset of action in the treatment of rosacea |
Feb, 2040
(16 years from now) | |
| US10933046 | GALDERMA LABS LP | Method for treatment of rosacea in patients aged 65 years and older |
Feb, 2040
(16 years from now) | |
| US11541026 | GALDERMA LABS LP | Method for treatment of rosacea |
Feb, 2040
(16 years from now) | |
| US11426378 | GALDERMA LABS LP | Method for long-term treatment of rosacea |
Aug, 2040
(17 years from now) | |
Do you want to check out EPSOLAY patents from before 2022?
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Product (NP) | Apr 22, 2025 |
Market Authorisation Date: 22 April, 2022
Treatment: Topical treatment of inflammatory lesions of rosacea in adults 18 years of age and older; Topical treatment of inflammatory lesions of rosacea in adults 65 years of age and older
Dosage: CREAM;TOPICAL
More Information on Dosage
EPSOLAY family patents
29
United States
7
IB
5
Canada
3
European Union
2
Israel
1
Korea, Republic of
1
China
1
Brazil
1
South Africa
1
EA
1
Japan
1
Australia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic